Natamycin

규격

7681-93-8CAS 번호

231-683-5EC 번호

(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acidIUPAC 명칭

C33H47NO13화학식

665.7 g/mol분자량

NATAMYCIN; pimaricin; 7681-93-8; Myprozine; Pimafucin; Tennecetin; Natacyn; Natamicina; Natamycine; Delvocid; Mycophyt; Pimaracin; Synogil; Natamycinum; Pimarizin; Antibiotic A-5283; Delvolan; Pimaricine; CL 12,625; 8O0C852CPO; INS NO.235; INS-235; NSC-759167; CL 12625; CL-12625; DTXCID301163; E-235; 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure; DTXSID6021163; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; CHEBI:7488; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; RefChem:56874; DTXCID501473823; (1R,3S,5R,7R,12R,22R,24S,25R,26S)-22-(((3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0^(5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; (1R*,3S*,5R*,7R*,8E,12R*,14E,16E,18E,20E,22R*,24S*,25R*,26S*)-22-(3-Amino-3,6-dideoxy-beta-D-mannopyranosyloxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; 231-683-5; 6,11,28-Trioxatricyclo(22.3.1.05,7)octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-; DTXSID201015573; MFCD00135085; Delvopos; Natafucin; Natamycin(Pimaricin); C33H47NO13; Tymasil; 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-; Pimarizin [German]; Natamycine [INN-French]; Natamycinum [INN-Latin]; Natamicina [INN-Spanish]; UNII-8O0C852CPO; Tennecetin;; Myprozine;; Natafucin;; Pimafucin;; Pimafugin;; Mycophyt;; Natacyn;; Synogil;; Natamycin [USAN:USP:INN:BAN]; NCGC00016686-01; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; 6,11,28-TRIOXATRICYCLO(22.3.1.05,7)OCTACOSA-8,14,16,18,20-PENTAENE-25-CARBOXYLIC ACID, 22-((3-AMINO-3,6-DIDEOXY-.BETA.-D-MANNOPYRANOSYL)OXY)-1,3,26-TRIHYDROXY-12-METHYL-10-OXO-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-; CAS-7681-93-8; EINECS 231-683-5; Pimaricin; Natamycin; Natamycin (Standard); NATAMYCIN [FCC]; NATAMYCIN [INN]; PIMARICIN [JAN]; NATAMYCIN [MI]; NATAMYCIN [USAN]; NATAMYCIN [VANDF]; NATAMYCIN [MART.]; NATAMYCIN [USP-RS]; NATAMYCIN [WHO-DD]; SCHEMBL18140; 0(5,7)]octacosa-8,14,16,18,20-pentaene-25-carboxylic ac; orb1310363; orb3025289; NATAMYCIN [ORANGE BOOK]; CHEMBL1200656; HY-B0133R; MSK2531; NATAMYCIN [USP MONOGRAPH]; NCXMLFZGDNKEPB-FFPOYIOWSA-N; Pimaricin 100 |Ig/mL in Water; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-(((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-(((2R,3S,4S,5S,6R)-4-Amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; EX-A1989; HY-B0133; Tox21_110561; BDBM50370755; EBC-27421; AKOS030485970; 73 - Natamycin (pimaricin) in cheese; AN26164; CS-1909; DB00826; NSC 759167; NICOTINAMIDE_ADENINE_DINUCLEOTIDE; Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; NS00003340; Natamycin, VETRANAL(TM), analytical standard; NCGC00373238-02_C33H47NO13_Delvocid; EN300-22411493; F806751; Pimaricin preparation, ~2.5%, aqueous suspension; Q248466; Fermentation product from Streptomyces chattanoogensis; Natamycin, United States Pharmacopeia (USP) Reference Standard; Pimaricin, from Streptomyces chattanoogensis, >=95% (HPLC); Natamycin, Pharmaceutical Secondary Standard; Certified Reference Material; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-|A-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid; (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0,5,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid동의어